ENTRY       D04024                      Drug
NAME        Lapatinib ditosylate (USAN);
            Lapatinib tosilate hydrate (JAN);
            Lapatinib ditosylate monohydrate;
            Tykerb (TN);
            Tyverb (TN)
PRODUCT     TYKERB (Novartis Pharmaceuticals Corporation)
  GENERIC   LAPATINIB (Lupin Pharmaceuticals)
FORMULA     C29H26ClFN4O4S. (C7H8O3S)2. H2O
EXACT_MASS  942.1841
MOL_WEIGHT  943.4761
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
               DG03158  HER2 inhibitor
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01EH01
            Chemical structure group: DG00715
            Product (DG00715): D04024<JP/US>
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
  DISEASE   Breast cancer (HER2 overexpressing) [DS:H00031]
TARGET      EGFR [HSA:1956] [KO:K04361]
            ERBB2* (HER2, CD340) [HSA_VAR:2064v1] [HSA:2064] [KO:K05083]
  PATHWAY   hsa04010(1956+2064)  MAPK signaling pathway
            hsa04012(1956+2064)  ErbB signaling pathway
            hsa05200(1956+2064)  Pathways in cancer
            hsa05224(1956+2064)  Breast cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]; CYP2C19 [HSA:1557], CYP2C8 [HSA:1558]
            Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
                 L01EH01 Lapatinib
                  D04024  Lapatinib ditosylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Lapatinib
                D04024  Lapatinib ditosylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03158  HER2 inhibitor
                 DG00715  Lapatinib
                  D04024  Lapatinib ditosylate
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG00715  Lapatinib
                D04024  Lapatinib ditosylate
              DG01639  CYP2C19 substrate
               DG00715  Lapatinib
                D04024  Lapatinib ditosylate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00715  Lapatinib
                 D04024  Lapatinib ditosylate
              DG02925  CYP3A5 substrate
               DG00715  Lapatinib
                D04024  Lapatinib ditosylate
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00715  Lapatinib
                D04024  Lapatinib ditosylate
              DG01913  ABCG2 substrate
               DG00715  Lapatinib
                D04024  Lapatinib ditosylate
            Drug classes [BR:br08332]
             Antineoplastic
              DG03158  HER2 inhibitor
               D04024  Lapatinib ditosylate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D04024  Lapatinib ditosylate (USAN) &lt;JP/US&gt;
                ERBB2* (HER2, CD340) [HSA_VAR:2064v1]
                 D04024  Lapatinib ditosylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04024
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04024
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04024
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04024
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04024
             Drug transporters
              D04024
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D04024
             Polymorphisms and mutations affecting drug response
              D04024
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03158  HER2 inhibitor
                 DG00715  Lapatinib
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG00715  Lapatinib
              DG01639  CYP2C19 substrate
               DG00715  Lapatinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00715  Lapatinib
              DG02925  CYP3A5 substrate
               DG00715  Lapatinib
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00715  Lapatinib
              DG01913  ABCG2 substrate
               DG00715  Lapatinib
DBLINKS     CAS: 388082-78-8
            PubChem: 17398008
            ChEBI: 192581
            LigandBox: D04024
ATOM        63
            1   O0  O    35.3225  -20.0361
            2   C8x C    19.9641  -13.5924
            3   N5x N    19.9641  -14.9937
            4   C8y C    21.1552  -15.6944
            5   C8y C    22.4164  -14.9937
            6   C8y C    22.4164  -13.5924
            7   N5x N    21.1552  -12.8917
            8   C8x C    23.6075  -15.6944
            9   C8y C    24.7987  -14.9937
            10  C8x C    24.7987  -13.5924
            11  C8x C    23.6075  -12.8917
            12  N1b N    21.1552  -17.0957
            13  C8y C    22.3464  -17.7964
            14  C8x C    22.3464  -19.1977
            15  C8y C    23.6075  -19.8983
            16  C8y C    24.7987  -19.1977
            17  C8x C    24.7987  -17.7964
            18  C8x C    23.6075  -17.0957
            19  X   Cl   23.6075  -21.2997
            20  O2a O    25.9898  -19.8983
            21  C1b C    27.1809  -19.1977
            22  C8y C    28.3720  -19.8983
            23  C8x C    28.3720  -21.2997
            24  C8x C    29.6332  -22.0003
            25  C8x C    30.8244  -21.2997
            26  C8y C    30.8244  -19.8983
            27  C8x C    29.6332  -19.1977
            28  X   F    32.0155  -19.1977
            29  C8y C    25.9898  -15.6944
            30  C8x C    26.4102  -17.0256
            31  C8x C    27.8115  -17.0256
            32  C8y C    28.2319  -15.6944
            33  O2x O    27.1109  -14.8536
            34  C1b C    29.4455  -14.9937
            35  N1b N    30.6591  -15.6944
            36  C1b C    31.8727  -14.9937
            37  C1b C    33.0862  -15.6944
            38  S4a S    34.2999  -14.9937
            39  C1a C    35.5134  -15.6944
            40  O1d O    35.2907  -14.0029
            41  O1d O    33.3089  -14.0029
            42  C8x C    38.4645  -17.4460
            43  C8x C    38.4645  -18.8473
            44  C8y C    39.6780  -19.5480
            45  C8x C    40.8917  -18.8473
            46  C8x C    40.8917  -17.4460
            47  C8y C    39.6780  -16.7454
            48  C1a C    39.6780  -20.9491
            49  S4a S    39.6780  -15.3442
            50  O1d O    39.6780  -13.9429
            51  O1d O    41.0794  -15.3442
            52  O1d O    38.2767  -15.3442
            53  C8x C    38.4645  -17.4460
            54  C8x C    38.4645  -18.8473
            55  C8y C    39.6780  -19.5480
            56  C8x C    40.8917  -18.8473
            57  C8x C    40.8917  -17.4460
            58  C8y C    39.6780  -16.7454
            59  S4a S    39.6780  -15.3442
            60  O1d O    39.6780  -13.9429
            61  O1d O    41.0794  -15.3442
            62  O1d O    38.2767  -15.3442
            63  C1a C    39.6780  -20.9491
BOND        66
            1     2   3 1
            2     3   4 2
            3     4   5 1
            4     5   6 1
            5     6   7 1
            6     2   7 2
            7     5   8 2
            8     8   9 1
            9     9  10 2
            10   10  11 1
            11    6  11 2
            12    4  12 1
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   13  18 1
            20   15  19 1
            21   16  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 2
            25   23  24 1
            26   24  25 2
            27   25  26 1
            28   26  27 2
            29   22  27 1
            30   26  28 1
            31    9  29 1
            32   30  31 1
            33   31  32 2
            34   32  33 1
            35   33  29 1
            36   30  29 2
            37   32  34 1
            38   34  35 1
            39   35  36 1
            40   36  37 1
            41   37  38 1
            42   38  39 1
            43   38  40 2
            44   38  41 2
            45   42  43 2
            46   43  44 1
            47   44  45 2
            48   45  46 1
            49   46  47 2
            50   42  47 1
            51   44  48 1
            52   47  49 1
            53   49  50 1
            54   49  51 2
            55   49  52 2
            56   53  54 2
            57   54  55 1
            58   55  56 2
            59   56  57 1
            60   57  58 2
            61   53  58 1
            62   55  63 1
            63   58  59 1
            64   59  60 1
            65   59  61 2
            66   59  62 2
BRACKET     1    37.6600  -21.8400   37.6600  -13.1600
            1    41.9300  -13.1600   41.9300  -21.8400
            1  2
  ORIGINAL  1   42  43  44  45  46  47  49  50  51  52  48
  REPEAT    1   53  54  55  56  57  58  59  60  61  62  63
///
